Common Stock, Shares, Issued of CITIUS ONCOLOGY, INC. from 31 Dec 2021 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
CITIUS ONCOLOGY, INC. quarterly Common Stock, Shares, Issued in shares history and change rate from 31 Dec 2021 to 31 Dec 2025.
  • CITIUS ONCOLOGY, INC. Common Stock, Shares, Issued for the quarter ending 31 Dec 2025 was 84,797,846, a 19% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)

CITIUS ONCOLOGY, INC. Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 84,797,846 +13,245,444 +19% 31 Dec 2025 10-Q 13 Feb 2026 2026 Q1
Q3 2025 83,513,442 +11,961,040 +17% 30 Sep 2025 10-Q 13 Feb 2026 2026 Q1
Q2 2025 71,552,402 +69,211,402 +2956% 30 Jun 2025 10-Q 12 Aug 2025 2025 Q3
Q1 2025 71,552,402 +69,211,402 +2956% 31 Mar 2025 10-Q 14 May 2025 2025 Q2
Q4 2024 71,552,402 +69,211,402 +2956% 31 Dec 2024 10-Q 14 Feb 2025 2025 Q1
Q3 2024 71,552,402 +4,052,402 +6% 30 Sep 2024 10-K 23 Dec 2025 2025 FY
Q2 2024 2,341,000 -75,000 -3.1% 30 Jun 2024 10-Q 09 Aug 2024 2024 Q2
Q1 2024 2,341,000 -75,000 -3.1% 31 Mar 2024 10-Q 20 May 2024 2024 Q1
Q4 2023 2,341,000 -75,000 -3.1% 31 Dec 2023 10-Q 09 Aug 2024 2024 Q2
Q3 2023 67,500,000 +65,775,000 +3813% 30 Sep 2023 10-K 27 Dec 2024 2024 FY
Q2 2023 2,416,000 30 Jun 2023 10-Q 16 Aug 2023 2023 Q2
Q1 2023 2,416,000 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 2,416,000 0 0% 31 Dec 2022 10-K 16 Apr 2024 2023 FY
Q3 2022 1,725,000 30 Sep 2022 10-Q 28 Nov 2022 2022 Q3
Q4 2021 2,416,000 31 Dec 2021 10-K 17 Apr 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.